Inspire Behavioral Health Logo

Covid-19 Restrictions Ending

COVID-19 Public Health Emergency Ending

As of May 11th, the COVID-19 Public Health Emergency is ending. During the Emergency, some requirements about prescribing controlled substances were temporarily waived, including the Ryan Haight Act of 2008 which places strict regulations on medications prescribed via telehealth appointments.


If you are a Inspire Behavioral Health patient who currently has a prescription for a controlled substance medication* and have not been seen in-person by your provider in the past 12 months, you will need to be seen in-person by your provider soon to continue receiving prescription refills for the medication.


Please discuss scheduling an in-person visit during your next appointment with your provider. Failure to see your provider in-person may prevent or delay your provider’s ability to refill your prescription.


We appreciate your understanding as we do our part to comply with the change in legal requirements. Please contact us with any questions or concerns at (703) 592-4600. Our team is available to support you through the transition. 

*Some common controlled substances include:

  • Adderall (amphetamine/dextroamphetamine)
  • Xanax (alprazolam)
  • Ambien (zolpidem)
  • Vyvanse (lisdexamfetamine)
  • Ritalin (methylphenidate)
  • Klonopin (clonazepam)
  • Concerta (methylphenidate)
  • Ativan (Lorazepam)

This is not an exhaustive list. If you are not sure whether your medication is a controlled substance, please contact your provider.